Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Post by Sandblaster1980on Aug 05, 2020 11:16pm
220 Views
Post# 31370612

THE HILL

THE HILLhttps://thehill.com/policy/healthcare/510561-us-urged-to-consider-cheaper-faster-covid-19-tests-to-contain-outbreaks


Only 1 out of 10 COVID-19 infections are being detected through testing, according to a recent CDC estimate. 

That is partly because a high percentage of infections — up to 45 percent — are thought to be asymptomatic, meaning they harbor the virus, and can transfer it to others, but won’t experience symptoms themselves. 

Regular screening using rapid tests will do a better job of finding people who have COVID-19 but aren’t showing symptoms, experts say.


Some interesting parts of the article.

 

Only 1 out of 10 COVID-19 infections are being detected through testing, according to a recent CDC estimate. 

That is partly because a high percentage of infections — up to 45 percent — are thought to be asymptomatic, meaning they harbor the virus, and can transfer it to others, but won’t experience symptoms themselves. 

Regular screening using rapid tests will do a better job of finding people who have COVID-19 but aren’t showing symptoms, experts say.


 

 

As far as paper antigen tests go, the Trump administration has indicated it sees a role for them, as long as they’re as accurate or sensitive as possible. 

“The FDA standard is over 80 percent and I think with what we're seeing with the antigen tests, that is not too high of a bar to achieve because several have achieved it,” Adm. Brett Giroir, the administration’s testing czar, told reporters last week, referring to the BD and Quidel machines.

“There are several more that are very low cost that would be in that range that are being considered.”


OK sona its teed up for you. LOL. GLTA

 


Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse